Evidence map›Paper›PMID 42633564›Full record

ArticleBioinformatics (Oxford, England)2026

GRASSP: RNA language model-enhanced graph attention with adaptive gating for RNA-small molecule binding site prediction.

Thi Lan Nguyen, Nguyen Quoc Khanh Le

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Thi Lan NguyenSchool of Electrical Engineering and Computer Science, The University of Queensland, St Lucia, Brisbane, QLD 4072, Australia.ORCID 0009-0006-0654-350X
Nguyen Quoc Khanh LeAIBioMed Lab, Taipei Medical University, Taipei 110, Taiwan.ORCID 0000-0003-4896-7926

Funding

National Science and Technology Council NSTC114-2221-E-038-015National Science and Technology Council NSTC115-2221-E-038-012-MY3
6 · The paper itself

Abstract

motivationRNA-small molecule binding site prediction is crucial for targeted drug discovery. Sequence-based methods are efficient but often fail to capture structural dependencies between nucleotides, whereas structure-aware graph models can better represent spatial interactions but typically rely on complex structural annotations and multi-stage preprocessing pipelines. We therefore developed GRASSP, a streamlined hybrid deep learning framework that integrates pretrained RNA language model (LM) representations with adaptive graph refinement.

resultsGRASSP leverages nucleotide embeddings and predicted secondary-structure features from a pretrained RNA LM to construct spatial RNA graphs, followed by a lightweight two-step graph attention refinement module with adaptive gating to capture local and contextual nucleotide dependencies. Across four benchmark datasets (TE18, HARIBOSS, TL12, and JL10), GRASSP generally outperformed state-of-the-art baselines, with improvements of up to 24.1% in AUC and 44.5% in MCC. Ablation analyses showed that pretrained RNA representations provided the dominant predictive contribution, while spatial graph refinement offered complementary but dataset-dependent benefits. These results demonstrate that GRASSP provides a competitive framework for integrating pretrained RNA representations with spatial structural context while reducing reliance on additional handcrafted structural annotations. AVAILABILITY: Code and datasets are publicly available at https://github.com/langiocn/GRASSP, with an archival snapshot available on Zenodo at https://doi.org/10.5281/zenodo.21888291.

Indexed as

Computational BiologyDeep LearningRNASoftwareBinding SitesRNA

Identifiers

PMID42633564
PMCPMC13544958

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.